Chargement en cours...
Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
Ph+ chronic myeloid leukemia (CML) is a clonal myeloproliferative disease whose clinical course is characterized by progression disease from the early chronic phase (CP) to the fatal blastic phase (BP). This programmed course is closely related to the translocation t(9;22)(q22;q11) and the resulting...
Enregistré dans:
| Publié dans: | J Clin Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7357035/ https://ncbi.nlm.nih.gov/pubmed/32498406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061709 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|